🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Genitourinary Cancers

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice NCT06103916n/a1 site📍 Veldhoven Maxima Medical Center · Tests: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasoun… The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site📍 Clermont-Ferrand Centre Jean Perrin · Tests: molecular analysis Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites📍 Fort Myers📍 Indianapolis📍 Cleveland Frantz Viral Therapeutics, LLC · Tests: Artesunate ointment, Placebo ointment Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian Endometriomas NCT07215130n/a1 site📍 Kanazawa Kanazawa University · Tests: Cavitron Ultrasonic Surgical Aspirator (CUSA) Clarity ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site📍 Liverpool Pierian Biosciences · Tests: No intervention Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer NCT03379909Phase 23 sites📍 Nijmegen📍 Rotterdam📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Metformin Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation NCT04228211n/a2 sites📍 Nieuwegein📍 Utrecht UMC Utrecht An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites📍 Duarte📍 La Jolla📍 Ann Arbor Incyte Corporation · Tests: INCA036873 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors NCT05366478Phase 11 site📍 Tianjin Suzhou BlueHorse Therapeutics Co., Ltd. · Tests: Autologous tumor infiltrating lymphocytes (TILs) WIRE - Novel Treatments in Renal Cell Cancer NCT03741426Phase 27 sites📍 Cambridge📍 Edinburgh📍 Exeter CCTU- Cancer Theme · Tests: Olaparib, Cediranib, Volrustomig, Rilvegostomig Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi NCT05551208Phase 21 site📍 Chongqing Chongqing University Cancer Hospital · Tests: fluzopanib and bevacizumab Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan NCT06099093Phase 42 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: 18F-DCFPyl 99mTc-P137 SPECT/CT in Prostate Cancer NCT05672485NA1 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: SPECT/CT imaging with 99mTc-P137 nuclide probe Intra-lesional Tumor Boost for Bulky Cervical Cancer NCT07435376Phase 21 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: intra-lesional boost IMRT, High Dose Rate Brachytherapy Cerebrovascular Disease: Quality of Life (CODE: QoL) NCT06443268n/a1 site📍 Zurich University of Zurich · Tests: questionnaire, hair samples, blood samples, clinical exam Prostate SABR With Intra-Prostatic SABR Boost NCT04212715Phase 21 site📍 Riyadh King Saud University · Tests: Pelvic SABR with intra-prostatic SABR A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies NCT05803018Phase 1, Phase 21 site📍 Shanghai Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-B01D1 Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell NCT07062549Phase 11 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: 111In-XYIMSR-01 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites📍 Birmingham📍 Boston📍 Boston Regeneron Pharmaceuticals · Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy NCT07144826EARLY Phase 11 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Placebo Administration, Probiotic, Questionnaire Administration Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries NCT05769517n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Germinal BRCA Prevalence and Clinical Implications of HPV Infection in Male IBD Patients NCT05911750n/a1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Anal pap smear and oral swab for cytology and HPV testing A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site📍 Tianjin Jacobio Pharmaceuticals Co., Ltd. · Tests: JAB-8263, JAB-8263 Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers NCT03413982n/a1 site📍 Kansas City University of Kansas Medical Center · Tests: Registry Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer NCT04823923NA5 sites📍 Marseille📍 Montpellier📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: blood sampling for ITK dosage
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy